secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2023-02-03T23:59:59+00:00
Accession:  0001372514-23-000008
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora enters private placement ($200K gross) and $10M committed equity line with Lincoln Park Capital
--------------------------------------------------------------------------------

- Issued 52,798 shares and 105,596 warrants at $3.788/share for $200K gross proceeds; warrants exercisable at $3.538.
- Committed equity facility allows Kiora to sell up to $10M in common stock to LPC over 36 months at prevailing market prices.
- Proceeds from both agreements to support clinical trials, working capital, and general corporate purposes.
- LPC precluded from short-selling or hedging Kiora's common stock under the Purchase Agreement.
- Kiora may terminate the Purchase Agreement at any time without cost or penalty.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000008/0001372514-23-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251423000008/kprx-20230203.htm
  HTML page:      https://secwatch.observer/filing/0001372514-23-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer